Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19

Atherosclerosis

28 April Apr 2021 16 days ago
  • Pontone G, Andreini D

The potential impact of coronary atherosclerosis, as detected by coronary artery calcium, on clinical outcomes in COVID-19 patients remains unsettled. We aimed to evaluate the prognostic impact of clinical and subclinical coronary artery disease (CAD), as assessed by coronary artery calcium score (CAC), in a large, unselected population of hospitalized COVID-19 patients undergoing non-gated chest computed tomography (CT) for clinical practice.

Reference

Scoccia A, Gallone G, Cereda A, Palmisano A, Vignale D, Leone R, Nicoletti V, Gnasso C, Monello A, Khokhar A, Sticchi A, Biagi A, Tacchetti C, Campo G, Rapezzi C, Ponticelli F, Danzi GB, Loffi M, Pontone G, Andreini D, Casella G, Iannopollo G, Ippolito D, Bellani G, Patelli G, Besana F, Costa C, Vignali L, Benatti G, Iannaccone M, Vaudano PG, Pacielli A, De Carlini CC, Maggiolini S, Bonaffini PA, Senni M, Scarnecchia E, Anastasio F, Colombo A, Ferrari R, Esposito A, Giannini F, Toselli M. Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19. Atherosclerosis 2021 Apr 7;S0021-9150(21)00165-9. doi: 10.1016/j.atherosclerosis.2021.03.041

Go to PubMed